Ubc9 Interacts with and SUMOylates the TCR Adaptor SLP-76 for NFAT Transcription in T Cells.


Journal

Journal of immunology (Baltimore, Md. : 1950)
ISSN: 1550-6606
Titre abrégé: J Immunol
Pays: United States
ID NLM: 2985117R

Informations de publication

Date de publication:
01 12 2019
Historique:
received: 14 05 2019
accepted: 30 09 2019
pubmed: 2 11 2019
medline: 28 5 2020
entrez: 1 11 2019
Statut: ppublish

Résumé

Although the immune adaptor SH2 domain containing leukocyte phosphoprotein of 76 kDa (SLP-76) integrates and propagates the TCR signaling, the regulation of SLP-76 during the TCR signaling is incompletely studied. In this article, we report that SLP-76 interacts with the small ubiquitin-like modifier (SUMO) E2 conjugase Ubc9 and is a substrate for Ubc9-mediated SUMOylation in human and mouse T cells. TCR stimulation promotes SLP-76-Ubc9 binding, accompanied by an increase in SLP-76 SUMOylation. Ubc9 binds to the extreme C terminus of SLP-76 spanning residues 516-533 and SUMOylates SLP-76 at two conserved residues K266 and K284. In addition, SLP-76 and Ubc9 synergizes to augment the TCR-mediated IL-2 transcription by NFAT in a manner dependent of SUMOylation of SLP-76. Moreover, although not affecting the TCR proximal signaling events, the Ubc9-mediated SUMOylation of SLP-76 is required for TCR-induced assembly of Ubc9-NFAT complex for IL-2 transcription. Together, these results suggest that Ubc9 modulates the function of SLP-76 in T cell activation both by direct interaction and by SUMOylation of SLP-76 and that the Ubc9-SLP-76 module acts as a novel regulatory complex in the control of T cell activation.

Identifiants

pubmed: 31666306
pii: jimmunol.1900556
doi: 10.4049/jimmunol.1900556
doi:

Substances chimiques

Adaptor Proteins, Signal Transducing 0
NFATC Transcription Factors 0
Phosphoproteins 0
Receptors, Antigen, T-Cell 0
SLP-76 signal Transducing adaptor proteins 0
Ubiquitin-Conjugating Enzymes EC 2.3.2.23
ubiquitin-conjugating enzyme UBC9 EC 6.3.2.-

Types de publication

Journal Article Research Support, Non-U.S. Gov't

Langues

eng

Sous-ensembles de citation

IM

Pagination

3023-3036

Informations de copyright

Copyright © 2019 by The American Association of Immunologists, Inc.

Auteurs

Yiwei Xiong (Y)

Department of Biological Sciences, Xi'an Jiaotong-Liverpool University, Suzhou, Jiangsu Province 215123, China.

Yulan Yi (Y)

Department of Biological Sciences, Xi'an Jiaotong-Liverpool University, Suzhou, Jiangsu Province 215123, China.

Yan Wang (Y)

Department of Biological Sciences, Xi'an Jiaotong-Liverpool University, Suzhou, Jiangsu Province 215123, China.

Naiqi Yang (N)

Department of Biological Sciences, Xi'an Jiaotong-Liverpool University, Suzhou, Jiangsu Province 215123, China.

Christopher E Rudd (CE)

Division of Immunology-Oncology Research Center, Maisonneuve-Rosemont Hospital, Montreal, Quebec H1T 2M4, Canada; and.
Département de Medicine, Université de Montréal, Montreal, Quebec H3C 3J7, Canada.

Hebin Liu (H)

Department of Biological Sciences, Xi'an Jiaotong-Liverpool University, Suzhou, Jiangsu Province 215123, China; hb1liu@foxmail.com.

Articles similaires

[Redispensing of expensive oral anticancer medicines: a practical application].

Lisanne N van Merendonk, Kübra Akgöl, Bastiaan Nuijen
1.00
Humans Antineoplastic Agents Administration, Oral Drug Costs Counterfeit Drugs

Smoking Cessation and Incident Cardiovascular Disease.

Jun Hwan Cho, Seung Yong Shin, Hoseob Kim et al.
1.00
Humans Male Smoking Cessation Cardiovascular Diseases Female
Humans United States Aged Cross-Sectional Studies Medicare Part C
1.00
Humans Yoga Low Back Pain Female Male

Classifications MeSH